Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway

Published:2018-04 Issue: Volume:100 Page:226-232
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yang Jing,Ren Xianyue,Zhang Liping,Li Yuanyuan,Cheng Bin,Xia Juan

Funder

National Natural Science Foundation of China

Science and Technology Project of Guangzhou City

Natural Science Foundation of Guangdong Provincial

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference36 articles.

1. Essentials of oral cancer;Rivera;Int. J. Clin. Exp. Pathol.,2015

2. Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma—a systematic review;Omar;Head Face Med.,2015

3. Late stage diagnosis of oral cancer: components and possible solutions;Güneri;Oral. Oncol.,2014

4. Biologic mechanisms of oral cancer pain and implications for clinical therapy;Viet;J. Dent. Res.,2012

5. Advances in the management of squamous cell carcinoma of the head and neck;Machiels;F1000Prime Rep.,2014

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of oridonin on sperm function and the PI3K/PDK1/AKT signaling pathway: Implications for reproductive toxicity;Reproductive Toxicology;2024-09

2. Naringin and temozolomide combination suppressed the growth of glioblastoma cells by promoting cell apoptosis: network pharmacology, in-vitro assays and metabolomics based study;Frontiers in Pharmacology;2024-07-30

3. LINC00342 regulates the PI3K-AKT signaling pathway via the miR-149-5p/FGF11 axis and affects the progression of oral cancer;2024-07-29

4. Procaine induces cell cycle arrest, apoptosis and autophagy through the inhibition of the PI3K/AKT and ERK pathways in human tongue squamous cell carcinoma;Oncology Letters;2024-06-28

5. Inhibition of ALDOA‐ and ENO1‐Mediated Glycolysis of Oridonin as a Novel Antitumor Strategy of Non‐Small‐Cell Lung Cancer;Advanced Therapeutics;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3